The 60-second version of Godavari Biorefineries Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹2,015 Cr | ₹1,687 Cr | ₹1,870 Cr | ₹1,988 Cr | -0.4% |
| EBITDA | ₹151 Cr | ₹143 Cr | ₹114 Cr | ₹138 Cr | -2.8% |
| EBITDA Margin | 7.5% | 8.5% | 6.1% | 7.0% | — |
| PAT (Net Profit) | ₹20 Cr | ₹12 Cr | -₹23 Cr | ₹4 Cr | -43.6% |
| EPS | ₹3.84 | ₹2.4 | ₹-5.11 | ₹0.69 | -43.6% |
| ROE | 4.0% | 2.5% | -3.0% | 0.4% | — |
| ROCE | 10.1% | 9.4% | 5.8% | 4.3% | — |
| Total Debt | ₹736 Cr | ₹655 Cr | ₹490 Cr | ₹531 Cr | -10.3% |
| Free Cash Flow | -₹20 Cr | ₹130 Cr | -₹72 Cr | ₹2 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| PIDILITE INDUSTRIES LTD | 57.8x | 24.4% |
| SRF LTD | 33.8x | 15.4% |
| UPL LIMITED | 21.5x | 6.1% |
Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 1 high-severity red flag sits above this conclusion and should be read first.